Presentation MDR TB at Abu Anja Teaching Hospital 1 (original) (raw)
A Study on Adverse Drug Reaction Profile of 2nd Line Drugs in Multi Drug Resistant (MDR) and Extensively Drug Resistant (XDR) Tuberculosis Cases Registered under DR-TB Centre in a Tertiary Care Hospital
Pronoy Sen
Journal of Evolution of Medical and Dental Sciences, 2020
View PDFchevron_right
Adverse events among patients of multi drug resistant tuberculosis receiving second line anti TB treatment
Vimlesh Pandey
View PDFchevron_right
Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study
Mehdi Mirsaeidi, Mohammad Reza Masjedi
Scandinavian Journal of Infectious Diseases, 2009
View PDFchevron_right
Acquired Resistance to Second-Line Drugs Among Persons With Tuberculosis in the United States
Julia Ershova
Clinical Infectious Diseases, 2012
View PDFchevron_right
Clinical Profile, Adverse Drug Reaction, and Outcome of Category V Patients at a Drug-resistant Tuberculosis Center, Mumbai
Ketaki Utpat
The Indian Journal of Chest Diseases and Allied Sciences
View PDFchevron_right
Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study
Ninoo George
View PDFchevron_right
Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed
Sarah Korver
2019
View PDFchevron_right
Long Term Follow up of Multi Drug Resistance Tuberculosis Patients After 3-4 Years of Starting Second Line Anti Tubercular Drugs
Muhammad Kashif Munir
2017
View PDFchevron_right
Management of multiple drug-resistant tuberculosis
Takashi Yoshiyama
Respiratory Medicine, 2003
View PDFchevron_right
Impact of Extensive Drug Resistance on Treatment Outcomes in Non–HIV‐Infected Patients with Multidrug‐Resistant Tuberculosis
Seung-sik Hwang
Clinical Infectious Diseases, 2007
View PDFchevron_right
The Outcome and Hepatic Function of an Extended Category II Treatment in a HIV-Seronegative Suspected Extensively Drug-Resistant TB Patient
Joseph Otchere
Journal of Diagnostics
View PDFchevron_right
Assessment of Multidrug Resistance Tuberclosis Treatment Outcome in St. Petre’s Tuberclosis Specialized Hospital, Addis Ababa, Ethiopia
Malaysian Journal of Medical and Biological Research MJMBR
View PDFchevron_right
Drug-Resistant Tuberculosis Types and Their Treatment Regimens Using First-Line, Second-Line Injectable, Third-Line, Fluoroquinolones, Aminoglycosides, Cyclic Polypeptides, Novel and Repurposed Anti-Tuberculosis Drugs
Geoffrey Kwenda
Journal of biomedical research & environmental sciences, 2022
View PDFchevron_right
Treatment outcomes associated with multidrug-resistant tuberculosis
Pankaj Jorwal
Journal of Global Infectious Diseases, 2018
View PDFchevron_right
Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study
Muluken Melese
BMC Public Health, 2013
View PDFchevron_right
The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome
Cüneyt Saltürk
Turkish Journal of Tuberculosis & Thorax, 2009
View PDFchevron_right
Outcome of Multidrug Resistant Tuberculosis at a Tertiary Care Hospital, Rahim Yar Khan
Masood Haq
Journal of Sheikh Zayed Medical College, 2020
View PDFchevron_right
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
Salmaan Keshavjee
European Respiratory Journal, 2012
View PDFchevron_right
in Patients with Tuberculosis and AIDS
Valéria Rolla
2009
View PDFchevron_right
Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First-and Second-line Drugs: An Individual Patient Data Meta-analysis
Dr Kefyalew Addis Alene
View PDFchevron_right
Second Line Drugs Resistant Mycobacterium Tuberculosis in Multi-Drug Resistant Tuberculosis Patients
Megha Raj Banjara
Journal of Institute of Science and Technology
View PDFchevron_right
Prevalence of Resistance to 1 Line Anti Tuberculosis Drugs at
Masood Haq
2016
View PDFchevron_right
Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis
Victoria Yorke-Edwards
The International Journal of Tuberculosis and Lung Disease, 2014
View PDFchevron_right
First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran
mehdi esmaeili
View PDFchevron_right
Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis
Nguyễn Thơm
BMC Infectious Diseases, 2018
View PDFchevron_right
Clinical profile of multi-drug reisitance tuberculosis in adults
Innovative Publication
Panacea Journal of Medical Sciences, 2023
View PDFchevron_right
Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance
Nafees Ahmed, I. Ahmad, A. Javaid
View PDFchevron_right
The Treatment Outcome of Multi Drug Resistant Tuberculosis in a Teaching Hospital
Sumitra Basuthakur
2009
View PDFchevron_right
Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country
Amer Khan
The European respiratory journal, 2017
View PDFchevron_right
Validation of MODS for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving TB treatment
Alberto Mendoza
Clinical Microbiology and Infection, 2013
View PDFchevron_right
Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment
Martien Borgdorff
PLoS ONE, 2010
View PDFchevron_right
DETECTION OF MULTIDRUG RESISTANT TUBERCULOSIS (MDR-TB) AMONG RIFAMPICIN-RESISTANT TB PATIENTS USING LINE PROBE ASSAY (LPA) IN KANO, NIGERIA
ABUBAKAR TUKUR, ABUBAKAR TUKUR
View PDFchevron_right
Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda
Francoise Portaels
International Journal of Infectious Diseases, 2008
View PDFchevron_right